Figure 1.
Effect of the selected drug compounds on the response of NF-κB reporter cells to IL-1β ± dexamethasone (dex). In vitro validation of the top five drug compounds from the Connectivity Map analysis in the Childhood Asthma Management Program and Severe Asthma Research Program III: (a) γ-linolenic-acid, (b) ampicillin, (c) exemestane, (d) brinzolamide, and (e) INCA-6. The luciferase activities of reporter cells treated with the drug compounds were compared to that of untreated cells. Data represent means ± standard errors compared using t-tests. * p < 0.05 (drug compounds vs. untreated in cells exposed to IL-1β alone); # p < 0.05 (drug compounds vs. untreated in cells exposed to IL-1β ± dex).